Alacris Theranostics GmbH

Alacris Theranostics GmbH

Fabeckstraße 60-62

14195 Berlin

Germany

undefinedWebsite

 

 

Project Leader

Prof. Hans Lehrach

Phone: +49 30 84131221

undefinedE-Mail

 

 

Project Team

Dr. Tatiana Borodina

Head of Sequencing

 

 

About Alacris Theranostics

Alacris Theranostics (www.alacris.de) is a company based in Berlin specialized in developing new approaches in personalized medicine for cancer patient diagnosis, treatment and drug stratification. Alacris Theranostics is applying a systems biology approach exclusively licensed as ModCellTM to Alacris. Based on genome and transcriptome information obtained by next generation sequencing and including kinetic pathway information, mutation and drug databases, the systems biology approach is providing a "Virtual Patient" model. The “Virtual Patient” model can predict the effect of drug treatment and optimized combinatory treatment providing means for truly personalized medicine approaches. In addition, Alacris' "Virtual Clinical Trials" system permits the in silico analysis of drugs, thus identifying stratified patient groups with particular genetic and molecular profiles that could be targeted by the drug, with the goal of more efficient drug development and approval.


The TREGeneration partners

Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

Paul Ehrlich Institute approves cGVHD Trial Read more

Social Media

LinkedIn TREGeneration